US20060078552A1
(en)
*
|
2002-03-15 |
2006-04-13 |
Sylvain Arnould |
Hybrid and single chain meganucleases and use thereof
|
US20100151556A1
(en)
*
|
2002-03-15 |
2010-06-17 |
Cellectis |
Hybrid and single chain meganucleases and use thereof
|
WO2009095742A1
(en)
|
2008-01-31 |
2009-08-06 |
Cellectis |
New i-crei derived single-chain meganuclease and uses thereof
|
JP4966006B2
(ja)
*
|
2003-01-28 |
2012-07-04 |
セレクティス |
カスタムメイドメガヌクレアーゼおよびその使用
|
US8409861B2
(en)
|
2003-08-08 |
2013-04-02 |
Sangamo Biosciences, Inc. |
Targeted deletion of cellular DNA sequences
|
US11311574B2
(en)
|
2003-08-08 |
2022-04-26 |
Sangamo Therapeutics, Inc. |
Methods and compositions for targeted cleavage and recombination
|
EP3222715A1
(en)
*
|
2003-08-08 |
2017-09-27 |
Sangamo BioSciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
US7888121B2
(en)
|
2003-08-08 |
2011-02-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for targeted cleavage and recombination
|
WO2006097784A1
(en)
*
|
2005-03-15 |
2006-09-21 |
Cellectis |
I-crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
AU2006224248B2
(en)
*
|
2005-03-15 |
2011-01-06 |
Cellectis |
I-Crei meganuclease variants with modified specificity, method of preparation and uses thereof
|
WO2007034262A1
(en)
*
|
2005-09-19 |
2007-03-29 |
Cellectis |
Heterodimeric meganucleases and use thereof
|
CN102286456B
(zh)
|
2005-04-04 |
2014-04-30 |
拜尔作物科学公司 |
用于去除所选择dna序列的方法和手段
|
US20140010797A1
(en)
*
|
2005-10-18 |
2014-01-09 |
Duke University |
Fusion Molecules of Rationally-Designed DNA-Binding Proteins and Effector Domains
|
EP2484758B1
(en)
|
2005-10-18 |
2013-10-02 |
Precision Biosciences |
Rationally-designed meganucleases with altered sequence specificity and DNA-binding affinity
|
WO2007060495A1
(en)
*
|
2005-10-25 |
2007-05-31 |
Cellectis |
I-crei homing endonuclease variants having novel cleavage specificity and use thereof
|
WO2007049095A1
(en)
*
|
2005-10-25 |
2007-05-03 |
Cellectis |
Laglidadg homing endonuclease variants having mutations in two functional subdomains and use thereof
|
WO2007093836A1
(en)
|
2006-02-13 |
2007-08-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a xp gene and uses thereof
|
US10407672B2
(en)
|
2006-03-27 |
2019-09-10 |
Seattle Children's Hospital |
Compositions and methods comprising the use of cell surface displayed homing endonucleases
|
US7951925B2
(en)
*
|
2006-05-25 |
2011-05-31 |
Sangamo Biosciences, Inc. |
Methods and compositions for gene inactivation
|
WO2008010009A1
(en)
*
|
2006-07-18 |
2008-01-24 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a rag gene and uses thereof
|
CA2664414C
(en)
|
2006-09-28 |
2016-07-12 |
Bayer Bioscience N.V. |
Methods and means for removal of a selected dna sequence
|
WO2008059317A1
(en)
*
|
2006-11-14 |
2008-05-22 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
|
US20100146651A1
(en)
*
|
2006-11-14 |
2010-06-10 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the hprt gene and uses thereof
|
EP2086644A2
(en)
*
|
2006-11-17 |
2009-08-12 |
Schering Corporation |
Combination of an inhibitor of dna polymerase-alpha and an inhibitor of a checkpoint kinase for proliferative disorders
|
WO2008093152A1
(en)
*
|
2007-02-01 |
2008-08-07 |
Cellectis |
Obligate heterodimer meganucleases and uses thereof
|
CN101679959A
(zh)
*
|
2007-02-19 |
2010-03-24 |
赛莱克蒂斯公司 |
具有新的底物特异性的laglidadg归巢核酸内切酶变体及其用途
|
WO2008102199A1
(en)
*
|
2007-02-20 |
2008-08-28 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the beta-2-microglobulin gene and uses thereof
|
CN101765661B
(zh)
*
|
2007-06-01 |
2014-08-06 |
索拉兹米公司 |
在微生物中生产油
|
JP2010528625A
(ja)
*
|
2007-06-01 |
2010-08-26 |
ビューロウ リサーチ エンタープライザズ リミティド ライアビリティ カンパニー |
トランスジェニック鳥においてヒトイディオタイプを有する抗体を生産するための組成物及び方法
|
CN101784664B
(zh)
|
2007-06-01 |
2013-04-10 |
Omt公司 |
用于抑制内源性免疫球蛋白基因和生产转基因人独特型抗体的组合物和方法
|
WO2008148559A1
(en)
|
2007-06-05 |
2008-12-11 |
Bayer Bioscience N.V. |
Methods and means for exact replacement of target dna in eukaryotic organisms
|
US20140112904A9
(en)
|
2007-06-06 |
2014-04-24 |
Cellectis |
Method for enhancing the cleavage activity of i-crei derived meganucleases
|
CA2691440A1
(en)
|
2007-06-29 |
2009-01-08 |
Pioneer Hi-Bred International, Inc. |
Methods for altering the genome of a monocot plant cell
|
WO2009013559A1
(en)
*
|
2007-07-23 |
2009-01-29 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof
|
WO2009019528A1
(en)
*
|
2007-08-03 |
2009-02-12 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human interleukin-2 receptor gamma chain gene and uses thereof
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
WO2009042163A2
(en)
*
|
2007-09-27 |
2009-04-02 |
Sangamo Biosciences, Inc. |
Rapid in vivo identification of biologically active nucleases
|
US11235026B2
(en)
|
2007-09-27 |
2022-02-01 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modulating PD1
|
EP3098309B1
(en)
*
|
2007-10-31 |
2019-04-10 |
Precision Biosciences, Inc. |
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
|
AU2008335324A1
(en)
*
|
2007-12-07 |
2009-06-18 |
Precision Biosciences, Inc. |
Rationally-designed meganucleases with recognition sequences found in DNase hypersensitive regions of the human genome
|
WO2009074842A1
(en)
*
|
2007-12-13 |
2009-06-18 |
Cellectis |
Improved chimeric meganuclease enzymes and uses thereof
|
SI2602325T1
(sl)
|
2008-02-29 |
2016-10-28 |
Monsanto Technology Llc |
Dogodek koruzne rastline MON87460 in sestavki ter postopki za njeno detekcijo
|
WO2009114321A2
(en)
*
|
2008-03-11 |
2009-09-17 |
Precision Biosciencs, Inc. |
Rationally-designed meganucleases for maize genome engineering
|
US20100071083A1
(en)
*
|
2008-03-12 |
2010-03-18 |
Smith James J |
Temperature-dependent meganuclease activity
|
WO2009146179A1
(en)
*
|
2008-04-15 |
2009-12-03 |
University Of Iowa Research Foundation |
Zinc finger nuclease for the cftr gene and methods of use thereof
|
CA2722797A1
(en)
*
|
2008-04-28 |
2009-11-05 |
Precision Biosciences, Inc. |
Fusion molecules of rationally-designed dna-binding proteins and effector domains
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
ES2625941T3
(es)
|
2008-07-14 |
2017-07-21 |
Precision Biosciences, Inc. |
Secuencias de reconocimiento para meganucleasas derivadas de i-crei y sus usos
|
EP2352821B1
(en)
*
|
2008-09-08 |
2016-11-23 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from a glutamine synthetase gene and uses thereof
|
EP2180058A1
(en)
|
2008-10-23 |
2010-04-28 |
Cellectis |
Meganuclease recombination system
|
JP6109475B2
(ja)
|
2008-11-28 |
2017-04-05 |
テラヴィア ホールディングス, インコーポレイテッド |
従属栄養微生物における、用途に応じた油の生産
|
US20110023139A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in cardiovascular disease
|
US20110023158A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Bovine genome editing with zinc finger nucleases
|
US20110023153A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in alzheimer's disease
|
US20110023143A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of neurodevelopmental genes in animals
|
US20110016546A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Porcine genome editing with zinc finger nucleases
|
US20110030072A1
(en)
*
|
2008-12-04 |
2011-02-03 |
Sigma-Aldrich Co. |
Genome editing of immunodeficiency genes in animals
|
US20110023148A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of addiction-related genes in animals
|
US20110023151A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of abc transporters
|
US20110023141A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved with parkinson's disease
|
US20110016540A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of genes associated with trinucleotide repeat expansion disorders in animals
|
US20110023144A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in amyotrophyic lateral sclerosis disease
|
US20110023140A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Rabbit genome editing with zinc finger nucleases
|
US20110023147A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of prion disorder-related genes in animals
|
US20110023145A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in autism spectrum disorders
|
US20110023152A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of cognition related genes in animals
|
US20110016541A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of sensory-related genes in animals
|
US20110023150A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genome editing of genes associated with schizophrenia in animals
|
US20110023156A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Feline genome editing with zinc finger nucleases
|
US20110023154A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Silkworm genome editing with zinc finger nucleases
|
US20110023149A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in tumor suppression in animals
|
US20110016539A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genome editing of neurotransmission-related genes in animals
|
US20110023146A1
(en)
*
|
2008-12-04 |
2011-01-27 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in secretase-associated disorders
|
US20110016543A1
(en)
*
|
2008-12-04 |
2011-01-20 |
Sigma-Aldrich Co. |
Genomic editing of genes involved in inflammation
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
EP2206723A1
(en)
|
2009-01-12 |
2010-07-14 |
Bonas, Ulla |
Modular DNA-binding domains
|
US20110294217A1
(en)
*
|
2009-02-12 |
2011-12-01 |
Fred Hutchinson Cancer Research Center |
Dna nicking enzyme from a homing endonuclease that stimulates site-specific gene conversion
|
JP5932632B2
(ja)
|
2009-03-20 |
2016-06-15 |
サンガモ バイオサイエンシーズ, インコーポレイテッド |
改変された亜鉛フィンガータンパク質を使用したcxcr4の修飾
|
WO2010122367A2
(en)
*
|
2009-04-21 |
2010-10-28 |
Cellectis |
Meganuclease variants cleaving the genomic insertion of a virus and uses thereof
|
US8772008B2
(en)
*
|
2009-05-18 |
2014-07-08 |
Sangamo Biosciences, Inc. |
Methods and compositions for increasing nuclease activity
|
WO2010136841A2
(en)
*
|
2009-05-26 |
2010-12-02 |
Cellectis |
Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
|
WO2010136981A2
(en)
*
|
2009-05-26 |
2010-12-02 |
Cellectis |
Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
AU2010266705B2
(en)
*
|
2009-06-30 |
2014-06-05 |
Sangamo Therapeutics, Inc. |
Rapid screening of biologically active nucleases and isolation of nuclease-modified cells
|
WO2011007193A1
(en)
|
2009-07-17 |
2011-01-20 |
Cellectis |
Viral vectors encoding a dna repair matrix and containing a virion-associated site specific meganuclease for gene targeting
|
US9234016B2
(en)
|
2009-07-28 |
2016-01-12 |
Sangamo Biosciences, Inc. |
Engineered zinc finger proteins for treating trinucleotide repeat disorders
|
AU2010282958B2
(en)
*
|
2009-08-11 |
2015-05-21 |
Sangamo Therapeutics, Inc. |
Organisms homozygous for targeted modification
|
WO2011021062A1
(en)
|
2009-08-21 |
2011-02-24 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the human lysosomal acid alpha-glucosidase gene and uses thereof
|
WO2011036640A2
(en)
|
2009-09-24 |
2011-03-31 |
Cellectis |
Meganuclease reagents of uses thereof for treating genetic diseases caused by frame shift/non sense mutations
|
CN102639695B
(zh)
|
2009-10-26 |
2015-01-21 |
独立行政法人农业生物资源研究所 |
转基因植物细胞的制造方法
|
WO2011072246A2
(en)
|
2009-12-10 |
2011-06-16 |
Regents Of The University Of Minnesota |
Tal effector-mediated dna modification
|
CA2793596A1
(en)
|
2009-12-30 |
2011-07-07 |
Pioneer Hi-Bred International, Inc. |
Methods and compositions for targeted polynucleotide modification
|
US20120329067A1
(en)
*
|
2010-01-22 |
2012-12-27 |
Barbas Iii Carlos F |
Methods of Generating Zinc Finger Nucleases Having Altered Activity
|
WO2011095475A1
(en)
|
2010-02-02 |
2011-08-11 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the diagnosis and therapy of retinitis pigmentosa
|
US20130045492A1
(en)
|
2010-02-08 |
2013-02-21 |
Regeneron Pharmaceuticals, Inc. |
Methods For Making Fully Human Bispecific Antibodies Using A Common Light Chain
|
US9796788B2
(en)
|
2010-02-08 |
2017-10-24 |
Regeneron Pharmaceuticals, Inc. |
Mice expressing a limited immunoglobulin light chain repertoire
|
SI3095871T1
(sl)
|
2010-02-08 |
2019-06-28 |
Regeneron Pharmaceuticals, Inc. |
Miš z navadno lahko verigo
|
WO2011101696A1
(en)
|
2010-02-18 |
2011-08-25 |
Cellectis |
Improved meganuclease recombination system
|
EP2539445B1
(en)
|
2010-02-26 |
2018-03-21 |
Cellectis |
Use of endonucleases for inserting transgenes into safe harbor loci
|
CA2794037A1
(en)
|
2010-03-22 |
2011-09-29 |
Philip Morris Products S.A. |
Modifying enzyme activity in plants
|
CA3066596A1
(en)
|
2010-04-23 |
2011-10-27 |
University Of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
CA2833905C
(en)
|
2010-04-23 |
2019-09-10 |
University Of Massachusetts |
Multicistronic expression constructs
|
CA2833912C
(en)
|
2010-04-23 |
2021-09-21 |
University Of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
US20130145487A1
(en)
|
2010-05-12 |
2013-06-06 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the dystrophin gene and uses thereof
|
EP2569435A1
(en)
*
|
2010-05-12 |
2013-03-20 |
Cellectis |
Meganuclease variants cleaving a dna target sequence from the rhodopsin gene and uses thereof
|
AU2011256838B2
(en)
|
2010-05-17 |
2014-10-09 |
Sangamo Therapeutics, Inc. |
Novel DNA-binding proteins and uses thereof
|
CA3039432A1
(en)
|
2010-05-28 |
2011-12-01 |
Corbion Biotech, Inc. |
Tailored oils produced from recombinant heterotrophic microorganisms
|
US20140148361A1
(en)
*
|
2010-06-07 |
2014-05-29 |
Barry L. Stoddard |
Generation and Expression of Engineered I-ONUI Endonuclease and Its Homologues and Uses Thereof
|
AU2011264075B2
(en)
|
2010-06-09 |
2015-01-29 |
Bayer Cropscience Nv |
Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
|
EP2580336B1
(en)
|
2010-06-09 |
2017-05-10 |
Bayer CropScience NV |
Methods and means to modify a plant genome at a nucleotide sequence commonly used in plant genome engineering
|
GB201009732D0
(en)
*
|
2010-06-10 |
2010-07-21 |
Gene Bridges Gmbh |
Direct cloning
|
WO2012001527A2
(en)
|
2010-06-15 |
2012-01-05 |
Cellectis S.A. |
Method for improving cleavage of dna by endonuclease sensitive to methylation
|
SG186932A1
(en)
|
2010-07-07 |
2013-02-28 |
Cellectis |
Meganucleases variants cleaving a dna target sequence in the nanog gene and uses thereof
|
WO2012010976A2
(en)
|
2010-07-15 |
2012-01-26 |
Cellectis |
Meganuclease variants cleaving a dna target sequence in the tert gene and uses thereof
|
WO2012007848A2
(en)
|
2010-07-16 |
2012-01-19 |
Cellectis |
Meganuclease variants cleaving a dna target sequence in the was gene and uses thereof
|
EP2412806B1
(en)
*
|
2010-07-28 |
2014-01-08 |
Institut Pasteur |
Use of terminal deoxynucleotidyl transferase for mutagenic DNA repair to generate variability, at a determined position in DNA
|
BR112013003135A2
(pt)
|
2010-08-13 |
2017-11-07 |
Pioneer Hi Bred Int |
polinucletídeo e polipeptídeo isolado ou recombinante, construto de ácido nucleico, célula, planta, explante vegetal, semente transgênica, método para produção de célula vegetal para controle de plantas daninhas e para detecção de um polipeptídeo hppd e um polinucleotídeo.
|
CA2815512A1
(en)
|
2010-10-27 |
2012-05-03 |
Philippe Duchateau |
Method for increasing the efficiency of double-strand break-induced mutagenesis
|
SG190154A1
(en)
|
2010-11-03 |
2013-06-28 |
Solazyme Inc |
Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
|
US9249436B2
(en)
|
2011-02-02 |
2016-02-02 |
Solazyme, Inc. |
Tailored oils produced from recombinant oleaginous microorganisms
|
US9044492B2
(en)
|
2011-02-04 |
2015-06-02 |
Cellectis Sa |
Method for modulating the efficiency of double-strand break-induced mutagenesis
|
AR085302A1
(es)
|
2011-02-24 |
2013-09-18 |
Sanofi Sa |
Metodo de produccion de anticuerpos sialilados
|
CA2828303C
(en)
|
2011-02-28 |
2020-04-07 |
Seattle Children's Research Institute |
Coupling endonucleases with end-processing enzymes drive high efficiency gene disruption
|
EP2689019A2
(en)
|
2011-03-23 |
2014-01-29 |
Pioneer Hi-Bred International Inc. |
Methods for producing a complex transgenic trait locus
|
WO2012138901A1
(en)
|
2011-04-05 |
2012-10-11 |
Cellectis Sa |
Method for enhancing rare-cutting endonuclease efficiency and uses thereof
|
US20140115726A1
(en)
|
2011-04-05 |
2014-04-24 |
Cellectis |
New tale-protein scaffolds and uses thereof
|
WO2012145624A2
(en)
|
2011-04-21 |
2012-10-26 |
University Of Massachusetts |
Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
EP2702160B1
(en)
|
2011-04-27 |
2020-05-27 |
Amyris, Inc. |
Methods for genomic modification
|
CN103796508B
(zh)
|
2011-05-02 |
2017-05-03 |
内布拉斯加大学评议会 |
具有有用性状的植物和相关方法
|
KR20140033378A
(ko)
|
2011-05-06 |
2014-03-18 |
솔라짐, 인코포레이티드 |
자일로오스를 대사시키는 유전자 조작된 미생물
|
WO2012158778A1
(en)
|
2011-05-16 |
2012-11-22 |
Cellectis S.A. |
Doubly secure transgenic algae or cyanobacteria strains to prevent their establishment and spread in natural ecosystems
|
EP3683319A1
(en)
|
2011-06-01 |
2020-07-22 |
Precision Biosciences, Inc. |
Methods and products for producing engineered mammalian cell lines with amplified transgenes
|
EP2729567B1
(en)
|
2011-07-08 |
2016-10-05 |
Cellectis |
Method for increasing the efficiency of double-strand break-induced mutagenssis
|
US9161995B2
(en)
*
|
2011-07-25 |
2015-10-20 |
Sangamo Biosciences, Inc. |
Methods and compositions for alteration of a cystic fibrosis transmembrane conductance regulator (CFTR) gene
|
RS61946B1
(sr)
|
2011-08-05 |
2021-07-30 |
Regeneron Pharma |
Humanizovani miševi univerzalnog lakog lakca
|
BR122014004140B8
(pt)
|
2011-08-22 |
2023-03-28 |
Bayer Cropscience Ag |
Vetor recombinante ou construção recombinante, bem como métodos para obter e produzir uma planta de algodão ou célula vegetal tolerante a um inibidor de hppd, e para cultivar um campo de plantas de algodão
|
WO2013053729A1
(en)
|
2011-10-12 |
2013-04-18 |
Bayer Cropscience Ag |
Plants with decreased activity of a starch dephosphorylating enzyme
|
BR112014008723A2
(pt)
|
2011-10-12 |
2019-09-24 |
Bayer Cropscience Ag |
plantas com diminuição da atividade de uma enzima de desforilação de àmido
|
EP2771457B1
(en)
*
|
2011-10-27 |
2017-11-22 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of the hprt locus
|
CN104039967A
(zh)
|
2012-01-06 |
2014-09-10 |
先锋高级育种国际公司 |
筛选植物的在植物中诱导孤雌生殖的遗传元件的方法
|
US20150166969A1
(en)
|
2012-02-24 |
2015-06-18 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for the treatment of hemoglobinopathies
|
CN108285491B
(zh)
|
2012-02-29 |
2021-08-10 |
桑格摩生物科学股份有限公司 |
治疗亨廷顿氏病的方法和组合物
|
EP2825190B1
(en)
|
2012-03-15 |
2016-11-30 |
Cellectis |
Repeat variable diresidues for targeting nucleotides
|
DK2828384T3
(en)
|
2012-03-23 |
2018-07-16 |
Cellectis |
PROCEDURE FOR SURVIVING SENSITIVITY TO CHEMICAL DNA MODIFICATIONS OF CONSTRUCTED SPEECH DNA BINDING DOMAINS
|
KR20150001830A
(ko)
|
2012-04-18 |
2015-01-06 |
솔라짐, 인코포레이티드 |
맞춤 오일
|
US9719114B2
(en)
|
2012-04-18 |
2017-08-01 |
Terravia Holdings, Inc. |
Tailored oils
|
WO2013160230A1
(en)
|
2012-04-23 |
2013-10-31 |
Bayer Cropscience Nv |
Targeted genome engineering in plants
|
US20150017136A1
(en)
|
2013-07-15 |
2015-01-15 |
Cellectis |
Methods for engineering allogeneic and highly active t cell for immunotherapy
|
KR102247979B1
(ko)
|
2012-05-25 |
2021-05-04 |
셀렉티스 |
면역요법을 위한 동종이형 및 면역억제제 저항성인 t 세포의 조작 방법
|
WO2013182910A2
(en)
|
2012-06-05 |
2013-12-12 |
Cellectis |
New transcription activator-like effector (tale) fusion protein
|
CA2877290A1
(en)
|
2012-06-19 |
2013-12-27 |
Daniel F. Voytas |
Gene targeting in plants using dna viruses
|
HUE030799T2
(en)
|
2012-07-11 |
2017-06-28 |
Sangamo Biosciences Inc |
Methods and preparations for the treatment of lysosomal storage diseases
|
US10648001B2
(en)
|
2012-07-11 |
2020-05-12 |
Sangamo Therapeutics, Inc. |
Method of treating mucopolysaccharidosis type I or II
|
EP2877488B1
(en)
|
2012-07-24 |
2021-02-24 |
Cellectis |
New modular base-specific nucleic acid binding domains from burkholderia rhizoxinica proteins
|
WO2014027615A1
(ja)
*
|
2012-08-16 |
2014-02-20 |
公立大学法人横浜市立大学 |
ミトコンドリア複合体iii欠乏症患者又は保因者の検出方法
|
WO2014033556A2
(en)
|
2012-09-03 |
2014-03-06 |
Cellectis |
Methods for modulating tal specificity
|
WO2014039523A1
(en)
|
2012-09-04 |
2014-03-13 |
Cellectis |
Multi-chain chimeric antigen receptor and uses thereof
|
EP2906684B8
(en)
|
2012-10-10 |
2020-09-02 |
Sangamo Therapeutics, Inc. |
T cell modifying compounds and uses thereof
|
US20150291967A1
(en)
|
2012-10-31 |
2015-10-15 |
Luc Mathis |
Coupling herbicide resistance with targeted insertion of transgenes in plants
|
EP2914094B1
(en)
|
2012-11-01 |
2021-07-21 |
Cellectis |
Plants for production of therapeutic proteins
|
EP2925779A1
(en)
|
2012-11-30 |
2015-10-07 |
Institut Pasteur |
Use of anti-fcyri and/or anti-fcyriia antibodies for treating arthritis, inflammation, thrombocytopenia and allergic shock
|
US20140178561A1
(en)
|
2012-12-21 |
2014-06-26 |
Cellectis |
Potatoes with reduced cold-induced sweetening
|
JP6583918B2
(ja)
|
2012-12-27 |
2019-10-02 |
キージーン ナムローゼ フェンノートシャップ |
植物における遺伝連鎖を解消するための方法
|
EP2951295B1
(en)
|
2013-02-01 |
2018-08-01 |
Cellectis |
Tevi chimeric endonucleases and their preferential cleavage sites
|
WO2014128659A1
(en)
|
2013-02-21 |
2014-08-28 |
Cellectis |
Method to counter-select cells or organisms by linking loci to nuclease components
|
WO2014158593A1
(en)
*
|
2013-03-13 |
2014-10-02 |
President And Fellows Of Harvard College |
Mutants of cre recombinase
|
US10113162B2
(en)
*
|
2013-03-15 |
2018-10-30 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the FAD2-1A/1B genes
|
CN105246324B
(zh)
*
|
2013-03-15 |
2018-08-28 |
塞尔克蒂斯股份有限公司 |
通过靶向敲除fad2-1a/1b基因来改良大豆油成分
|
KR102220382B1
(ko)
|
2013-05-13 |
2021-02-25 |
셀렉티스 |
면역요법을 위한 매우 활성인 t 세포를 조작하는 방법
|
AU2014279694B2
(en)
|
2013-06-14 |
2020-07-23 |
Cellectis |
Methods for non-transgenic genome editing in plants
|
MX2016002118A
(es)
|
2013-08-22 |
2016-06-28 |
Du Pont |
Modificacion del genoma de plantas por medio del uso de sistemas de ácido ribonucléico (arn) guía/ endonucleasa cas y metodos de uso.
|
US10767188B2
(en)
|
2013-09-25 |
2020-09-08 |
Nutech Ventures |
Methods and compositions for obtaining useful plant traits
|
US10053715B2
(en)
|
2013-10-04 |
2018-08-21 |
Corbion Biotech, Inc. |
Tailored oils
|
KR102251168B1
(ko)
|
2013-10-25 |
2021-05-13 |
셀렉티스 |
고 반복 모티프를 포함하는 dna 서열에 대한 효율적이고 특이적인 표적화를 위한 희소-절단 엔도뉴클레아제의 설계
|
CA2929179A1
(en)
|
2013-11-11 |
2015-05-14 |
Sangamo Biosciences, Inc. |
Htt genetic repressor, viral vector, and uses thereof
|
US9476065B2
(en)
|
2013-12-19 |
2016-10-25 |
Amyris, Inc. |
Methods for genomic integration
|
DK3083671T3
(da)
|
2013-12-20 |
2020-12-07 |
Hutchinson Fred Cancer Res |
Mærkede kimære effektormolekyler og receptorer deraf
|
ES2821149T3
(es)
*
|
2014-03-12 |
2021-04-23 |
Prec Biosciences Inc |
Eliminación del exón del gen de la distrofina mediante nucleasas modificadas genéticamente
|
US9624498B2
(en)
|
2014-03-18 |
2017-04-18 |
Sangamo Biosciences, Inc. |
Methods and compositions for regulation of zinc finger protein expression
|
WO2015143078A1
(en)
|
2014-03-18 |
2015-09-24 |
University Of Massachusetts |
Raav-based compositions and methods for treating amyotrophic lateral sclerosis
|
WO2015143177A1
(en)
|
2014-03-21 |
2015-09-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Genome editing without nucleases
|
US10881085B2
(en)
|
2014-03-21 |
2021-01-05 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that make single domain binding proteins
|
US10689653B2
(en)
|
2014-06-03 |
2020-06-23 |
University Of Massachusetts |
Compositions and methods for modulating dysferlin expression
|
CA2952906A1
(en)
|
2014-06-20 |
2015-12-23 |
Cellectis |
Potatoes with reduced granule-bound starch synthase
|
ES2764273T3
(es)
|
2014-07-10 |
2020-06-02 |
Corbion Biotech Inc |
Nuevos genes de cetoacil ACP sintasa y uso de los mismos
|
EP3200830B1
(en)
|
2014-10-03 |
2020-09-09 |
University of Massachusetts |
High efficiency library-identified aav vectors
|
US10370432B2
(en)
|
2014-10-03 |
2019-08-06 |
University Of Massachusetts |
Heterologous targeting peptide grafted AAVS
|
RU2738421C2
(ru)
|
2014-10-21 |
2020-12-14 |
Юниверсити Оф Массачусетс |
Варианты рекомбинантных aav и их применения
|
EP3233897B1
(en)
|
2014-12-19 |
2021-02-17 |
Universite de Nantes |
Anti il-34 antibodies
|
AU2016214048A1
(en)
|
2015-02-02 |
2017-08-24 |
Cellectis |
Agrobacterium-mediated genome modification without T-DNA integration
|
US10584321B2
(en)
|
2015-02-13 |
2020-03-10 |
University Of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
EP3271403A1
(en)
|
2015-03-19 |
2018-01-24 |
Regeneron Pharmaceuticals, Inc. |
Non-human animals that select for light chain variable regions that bind antigen
|
WO2016154579A2
(en)
*
|
2015-03-26 |
2016-09-29 |
Editas Medicine, Inc. |
Crispr/cas-mediated gene conversion
|
ES2959608T3
(es)
|
2015-04-03 |
2024-02-27 |
Dana Farber Cancer Inst Inc |
Composición y métodos de edición del genoma de células B
|
CA3021949C
(en)
|
2015-04-24 |
2023-10-17 |
University Of Massachusetts |
Modified aav constructs and uses thereof
|
US11827904B2
(en)
|
2015-04-29 |
2023-11-28 |
Fred Hutchinson Cancer Center |
Modified stem cells and uses thereof
|
WO2016179112A1
(en)
|
2015-05-01 |
2016-11-10 |
Precision Biosciences, Inc. |
Precise deletion of chromoscomal sequences in vivo and treatment of nucleotide repeat expansion disorders using engineered nucleases
|
US11845928B2
(en)
|
2015-05-04 |
2023-12-19 |
Tsinghua University |
Methods and kits for fragmenting DNA
|
AU2016262093B2
(en)
|
2015-05-13 |
2022-08-18 |
Seattle Children' S Hospital (Dba Seattle Children 's Research Institute) |
Enhancing endonuclease based gene editing in primary cells
|
CN107920486B
(zh)
|
2015-06-30 |
2023-06-20 |
明尼苏达大学董事会 |
用于加速基因组编辑的单倍体诱导系
|
EP3325668B1
(en)
|
2015-07-23 |
2021-01-06 |
Mayo Foundation for Medical Education and Research |
Editing mitochondrial dna
|
WO2017029833A1
(ja)
*
|
2015-08-20 |
2017-02-23 |
大学共同利用機関法人情報・システム研究機構 |
動物細胞ゲノム部位特異的外来dna挿入方法及び前記挿入方法を用いて得られる細胞
|
US10837024B2
(en)
|
2015-09-17 |
2020-11-17 |
Cellectis |
Modifying messenger RNA stability in plant transformations
|
WO2017070525A1
(en)
|
2015-10-22 |
2017-04-27 |
University Of Massachusetts |
Methods and compositions for treating metabolic imbalance in neurodegenerative disease
|
WO2017070516A1
(en)
|
2015-10-22 |
2017-04-27 |
University Of Massachusetts |
Prostate-targeting adeno-associated virus serotype vectors
|
WO2017079428A1
(en)
|
2015-11-04 |
2017-05-11 |
President And Fellows Of Harvard College |
Site specific germline modification
|
EA201891212A1
(ru)
|
2015-12-18 |
2019-01-31 |
Сангамо Терапьютикс, Инк. |
Адресная дезорганизация клеточного рецептора гкгс
|
CA3008413A1
(en)
|
2015-12-18 |
2017-06-22 |
Sangamo Therapeutics, Inc. |
Targeted disruption of the t cell receptor
|
MX2018008345A
(es)
|
2016-01-11 |
2018-12-06 |
Univ Leland Stanford Junior |
Proteínas quiméricas y métodos de inmunoterapia.
|
US9856497B2
(en)
|
2016-01-11 |
2018-01-02 |
The Board Of Trustee Of The Leland Stanford Junior University |
Chimeric proteins and methods of regulating gene expression
|
WO2017134601A1
(en)
|
2016-02-02 |
2017-08-10 |
Cellectis |
Modifying soybean oil composition through targeted knockout of the fad3a/b/c genes
|
US11826433B2
(en)
|
2016-02-02 |
2023-11-28 |
University Of Massachusetts |
Method to enhance the efficiency of systemic AAV gene delivery to the central nervous system
|
EP4094780A3
(en)
|
2016-02-12 |
2023-02-08 |
University of Massachusetts |
Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
|
EP3420093B1
(en)
|
2016-02-26 |
2022-11-23 |
Cellectis |
Micelle based system nuclease encapsulation for in-vivo gene editing
|
US11340233B2
(en)
|
2016-03-07 |
2022-05-24 |
Pierre Fabre Medicament |
Universal method to capture and analyze ADCs for characterization of drug distribution and the drug-to-antibody ratio in biological samples
|
EP3440210A4
(en)
|
2016-04-05 |
2019-11-27 |
University of Massachusetts |
COMPOSITIONS AND METHODS FOR SELECTIVE INHIBITION OF EXPRESSION OF GRAINHEAD PROTEIN
|
WO2017180859A1
(en)
*
|
2016-04-13 |
2017-10-19 |
University Of Massachusetts |
Repairing compound heterozygous recessive mutations by allele exchange
|
WO2017181105A1
(en)
|
2016-04-15 |
2017-10-19 |
University Of Massachusetts |
Methods and compositions for treating metabolic imbalance
|
US11278632B2
(en)
|
2016-05-03 |
2022-03-22 |
Precision Biosciences, Inc. |
Engineered nucleases useful for treatment of hemophilia A
|
WO2017201311A2
(en)
|
2016-05-18 |
2017-11-23 |
Amyris, Inc. |
Compositions and methods for genomic integration of nucleic acids into exogenous landing pads
|
US11021713B2
(en)
|
2016-05-25 |
2021-06-01 |
Cargill, Incorporated |
Engineered nucleases to generate deletion mutants in plants
|
EA201892624A1
(ru)
|
2016-05-26 |
2019-06-28 |
Нунхемс Б.В. |
Растения, дающие бессемянные плоды
|
CN113907043B
(zh)
|
2016-06-03 |
2023-08-01 |
瑞泽恩制药公司 |
表达外源末端脱氧核苷酸转移酶的非人动物
|
WO2017218852A1
(en)
|
2016-06-15 |
2017-12-21 |
University Of Massachusetts |
Recombinant adeno-associated viruses for delivering gene editing molecules to embryonic cells
|
CA3029271A1
(en)
|
2016-06-28 |
2018-01-04 |
Cellectis |
Altering expression of gene products in plants through targeted insertion of nucleic acid sequences
|
CA3029761A1
(en)
|
2016-07-06 |
2018-01-11 |
Cellectis |
Sequential gene editing in primary immune cells
|
MA45996A
(fr)
*
|
2016-08-16 |
2021-06-02 |
Bluebird Bio Inc |
Variants d'endonucléase de homing du récepteur alpha de l'il-10, compositions et méthodes d'utilisation associées
|
US20190211349A1
(en)
|
2016-08-18 |
2019-07-11 |
Cellectis |
Black-spot resistant potatoes with reduced tuber-specific polyphenol oxidase activity
|
EP3504327B1
(en)
|
2016-08-24 |
2021-10-06 |
Sangamo Therapeutics, Inc. |
Engineered target specific nucleases
|
US20200002709A1
(en)
|
2016-09-01 |
2020-01-02 |
Cellectis |
Methods for altering amino acid content in plants
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
BR112019005633A8
(pt)
|
2016-09-23 |
2023-04-11 |
Hutchinson Fred Cancer Res |
Tcrs específicos para antigênio ha-1 de histocompatibilidade (h) menor e usos dos mesmos
|
US20190225974A1
(en)
|
2016-09-23 |
2019-07-25 |
BASF Agricultural Solutions Seed US LLC |
Targeted genome optimization in plants
|
KR20190075964A
(ko)
|
2016-10-13 |
2019-07-01 |
유니버시티 오브 매사추세츠 |
Aav 캡시드 설계
|
WO2018073391A1
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Targeted gene insertion for improved immune cells therapy
|
CA3042857A1
(en)
|
2016-11-16 |
2018-05-24 |
Cellectis |
Methods for altering amino acid content in plants through frameshift mutations
|
US11192929B2
(en)
|
2016-12-08 |
2021-12-07 |
Regents Of The University Of Minnesota |
Site-specific DNA base editing using modified APOBEC enzymes
|
WO2018115189A1
(en)
|
2016-12-21 |
2018-06-28 |
Cellectis |
Stably enginereed proteasome inhibitor resistant immune cells for immunotherapy
|
AU2018210420A1
(en)
|
2017-01-19 |
2019-08-08 |
Omniab, Inc. |
Human antibodies from transgenic rodents with multiple heavy chain immunoglobulin loci
|
EA201992131A1
(ru)
|
2017-03-15 |
2020-02-06 |
Фред Хатчинсон Кэнсер Рисерч Сентер |
Высокоаффинные специфичные к mage-a1 tcr и их применение
|
EP3592854A1
(en)
|
2017-04-13 |
2020-01-15 |
Cellectis |
New sequence specific reagents targeting ccr5 in primary hematopoietic cells
|
EP3392339A1
(en)
|
2017-04-18 |
2018-10-24 |
Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen |
Improved genome editing in plant cells
|
JP2020517255A
(ja)
*
|
2017-04-21 |
2020-06-18 |
プレシジョン バイオサイエンシズ,インク. |
Pcsk9遺伝子の認識配列に特異的な操作されたメガヌクレアーゼ
|
CA3060622A1
(en)
|
2017-04-25 |
2018-11-01 |
Cellectis |
Alfalfa with reduced lignin composition
|
IL301115A
(en)
|
2017-04-28 |
2023-05-01 |
Acuitas Therapeutics Inc |
New lipid carbonyl and lipid nanoparticle formulations for delivery of nucleic acids
|
CA3059793A1
(en)
|
2017-05-03 |
2018-11-08 |
Sangamo Therapeutics, Inc. |
Methods and compositions for modification of a cystic fibrosis transmembrane conductance regulator (cftr) gene
|
WO2018208972A1
(en)
|
2017-05-09 |
2018-11-15 |
University Of Massachusetts |
Methods of treating amyotrophic lateral sclerosis (als)
|
WO2018206791A1
(en)
|
2017-05-12 |
2018-11-15 |
Cellectis |
Protease based switch chimeric antigen receptors for safer cell immunotherapy
|
CA3064000A1
(en)
|
2017-05-24 |
2018-11-29 |
Effector Therapeutics, Inc. |
Methods and compositions for cellular immunotherapy
|
EP3630962A4
(en)
|
2017-05-25 |
2021-01-20 |
Bluebird Bio, Inc. |
CBLB ENDONUCLEASE VARIANTS, COMPOSITIONS AND METHODS OF USE
|
WO2018234239A1
(en)
|
2017-06-19 |
2018-12-27 |
Cellectis |
ANTI-HBV POLYTHERAPIES INVOLVING SPECIFIC ENDONUCLEASES
|
US11332749B2
(en)
|
2017-07-13 |
2022-05-17 |
Regents Of The University Of Minnesota |
Real-time reporter systems for monitoring base editing
|
WO2019016360A1
(en)
|
2017-07-21 |
2019-01-24 |
Cellectis |
MODIFIED IMMUNE CELLS RESISTANT TO TUMOR MICRO-ENVIRONMENT
|
AU2018327225A1
(en)
|
2017-09-06 |
2020-02-27 |
Fred Hutchinson Cancer Center |
Strep-tag specific chimeric receptors and uses thereof
|
WO2019051135A1
(en)
|
2017-09-06 |
2019-03-14 |
Fred Hutchinson Cancer Research Center |
METHODS FOR IMPROVING ADOPTIVE CELL THERAPY
|
JP7397488B2
(ja)
|
2017-09-22 |
2023-12-13 |
ユニバーシティ オブ マサチューセッツ |
Sod1二重発現ベクターおよびその使用
|
WO2019076486A1
(en)
|
2017-10-19 |
2019-04-25 |
Cellectis |
TARGETED GENE INTEGRATION OF NK INHIBITOR GENES FOR ENHANCED IMMUNE CELL THERAPY
|
US20210069241A1
(en)
|
2017-10-20 |
2021-03-11 |
Fred Hutchinson Cancer Research Center |
Compositions and methods of immunotherapy targeting tigit and/or cd112r or comprising cd226 overexpression
|
US20200299658A1
(en)
*
|
2017-11-01 |
2020-09-24 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
WO2019106163A1
(en)
|
2017-12-01 |
2019-06-06 |
Cellectis |
Reprogramming of genetically engineered primary immune cells
|
WO2019109047A1
(en)
|
2017-12-01 |
2019-06-06 |
Fred Hutchinson Cancer Research Center |
Binding proteins specific for 5t4 and uses thereof
|
CA3084687C
(en)
|
2017-12-05 |
2024-01-02 |
Progastrine Et Cancers S.A R.L. |
Combination therapy between anti-progastrin antibody and immunotherapy to treat cancer
|
WO2019129850A1
(en)
|
2017-12-29 |
2019-07-04 |
Cellectis |
Off-the-shelf engineered cells for therapy
|
WO2019140278A1
(en)
|
2018-01-11 |
2019-07-18 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting core binding factor antigens
|
BR112020014168A2
(pt)
|
2018-01-12 |
2020-12-08 |
Basf Se |
Proteína, ácido nucleico isolado, gene recombinante, vetor, célula hospedeira, planta, parte de planta ou semente de trigo, métodos para produzir, produto de trigo, farinha, farelo integral, amido, grânulos de amido ou farelo de trigo e métodos para identificar e/ou selecionar uma planta de trigo
|
JP2021514631A
(ja)
|
2018-02-26 |
2021-06-17 |
フレッド ハッチンソン キャンサー リサーチ センター |
細胞免疫療法のための組成物および方法
|
AU2019228339A1
(en)
|
2018-02-27 |
2020-09-10 |
Ecs-Progastrin Sa |
Progastrin as a biomarker for immunotherapy
|
WO2019204226A1
(en)
|
2018-04-16 |
2019-10-24 |
University Of Massachusetts |
Compositions and methods for improved gene editing
|
JP2021521874A
(ja)
|
2018-05-02 |
2021-08-30 |
セレクティスCellectis |
増大した食物繊維を含むコムギの操作
|
US11690921B2
(en)
|
2018-05-18 |
2023-07-04 |
Sangamo Therapeutics, Inc. |
Delivery of target specific nucleases
|
EP3802839A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Nucleic acid constructs and methods of using same
|
EP3800998A1
(en)
|
2018-06-07 |
2021-04-14 |
The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center) |
Methods of regenerating and transforming cannabis
|
WO2019238832A1
(en)
|
2018-06-15 |
2019-12-19 |
Nunhems B.V. |
Seedless watermelon plants comprising modifications in an abc transporter gene
|
US11624072B2
(en)
|
2018-07-09 |
2023-04-11 |
Cellectis |
Canola with high oleic acid
|
BR112021000934A2
(pt)
|
2018-07-20 |
2021-04-27 |
Pierre Fabre Medicament |
receptor para vista
|
WO2020018964A1
(en)
|
2018-07-20 |
2020-01-23 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for controlled expression of antigen-specific receptors
|
WO2020041501A1
(en)
|
2018-08-22 |
2020-02-27 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting kras or her2 antigens
|
EP3844266A1
(en)
|
2018-08-28 |
2021-07-07 |
Fred Hutchinson Cancer Research Center |
Methods and compositions for adoptive t cell therapy incorporating induced notch signaling
|
CA3111711A1
(en)
|
2018-09-18 |
2020-03-26 |
Sangamo Therapeutics, Inc. |
Programmed cell death 1 (pd1) specific nucleases
|
WO2020068702A1
(en)
|
2018-09-24 |
2020-04-02 |
Fred Hutchinson Cancer Research Center |
Chimeric receptor proteins and uses thereof
|
WO2020065096A1
(en)
|
2018-09-28 |
2020-04-02 |
Pierre Fabre Medicament |
New immunocytokines for the treatment of cancer
|
WO2020072059A1
(en)
|
2018-10-04 |
2020-04-09 |
Bluebird Bio, Inc. |
Cblb endonuclease variants, compositions, and methods of use
|
MX2021005308A
(es)
|
2018-11-09 |
2021-09-08 |
Fred Hutchinson Cancer Center Star |
Receptores de celulas t especificos para mesotelina y su uso en inmunoterapia.
|
US20220064657A1
(en)
|
2019-01-04 |
2022-03-03 |
Cargill, Incorporated |
Engineered nucleases to generate mutations in plants
|
CN113474328A
(zh)
|
2019-01-11 |
2021-10-01 |
爱康泰生治疗公司 |
用于脂质纳米颗粒递送活性剂的脂质
|
EP3927727A1
(en)
|
2019-02-20 |
2021-12-29 |
Fred Hutchinson Cancer Research Center |
Binding proteins specific for ras neoantigens and uses thereof
|
WO2020181101A1
(en)
|
2019-03-07 |
2020-09-10 |
The Regents Of The University Of California |
Crispr-cas effector polypeptides and methods of use thereof
|
CN113784978A
(zh)
|
2019-03-11 |
2021-12-10 |
弗雷德哈钦森癌症研究中心 |
高亲合力wt1 t细胞受体及其用途
|
WO2020257684A1
(en)
|
2019-06-20 |
2020-12-24 |
University Of Massachusetts |
Compositions and methods for improved gene editing
|
US20220409661A1
(en)
|
2019-08-20 |
2022-12-29 |
Fred Hutchinson Cancer Research Center |
T-cell immunotherapy specific for wt-1
|
AU2020342910A1
(en)
|
2019-09-04 |
2022-04-07 |
Pierre Fabre Medicament |
Anti-VSIG4 antibody or antigen binding fragment and uses thereof
|
EP4030895A1
(en)
|
2019-09-20 |
2022-07-27 |
Calyxt, Inc. |
Low phytoestrogen soybean based on gene editing
|
WO2021108248A1
(en)
|
2019-11-27 |
2021-06-03 |
Calyxt, Inc. |
Tal-effector nucleases for gene editing
|
US20230227559A1
(en)
|
2019-12-10 |
2023-07-20 |
Institut Pasteur |
New antibody blocking human fcgriiia and fcgriiib
|
KR20220118532A
(ko)
|
2019-12-23 |
2022-08-25 |
셀렉티스 |
고형 종양들 암 면역요법을 위한 새로운 메소텔린 특이적 키메라 항원 수용체들 (car)
|
EP4058467A1
(en)
|
2019-12-24 |
2022-09-21 |
Selexis SA |
Targeted integration in mammalian sequences enhancing gene expression
|
US20230062896A1
(en)
|
2020-01-31 |
2023-03-02 |
Calyxt, Inc. |
Increase of saturated fat in soybean
|
EP3889183A1
(en)
|
2020-04-01 |
2021-10-06 |
Pierre Fabre Medicament |
A protein complex comprising an immunocytokine
|
CA3177621A1
(en)
|
2020-05-06 |
2021-11-11 |
Alexandre Juillerat |
Methods to genetically modify cells for delivery of therapeutic proteins
|
EP4146812A1
(en)
|
2020-05-06 |
2023-03-15 |
Cellectis S.A. |
Methods for targeted insertion of exogenous sequences in cellular genomes
|
US20230242900A1
(en)
*
|
2020-07-16 |
2023-08-03 |
The Texas A&M University System |
Self-eliminating transgenes
|
WO2022016070A1
(en)
|
2020-07-16 |
2022-01-20 |
Acuitas Therapeutics, Inc. |
Cationic lipids for use in lipid nanoparticles
|
US20230248825A1
(en)
|
2020-07-24 |
2023-08-10 |
Cellectis S.A. |
T-cells expressing immune cell engagers in allogenic settings
|
EP4204545A2
(en)
|
2020-08-25 |
2023-07-05 |
Kite Pharma, Inc. |
T cells with improved functionality
|
WO2022066973A1
(en)
|
2020-09-24 |
2022-03-31 |
Fred Hutchinson Cancer Research Center |
Immunotherapy targeting pbk or oip5 antigens
|
JP2023542528A
(ja)
|
2020-09-24 |
2023-10-10 |
フレッド ハッチンソン キャンサー センター |
Sox2抗原を標的とする免疫療法
|
US10947552B1
(en)
|
2020-09-30 |
2021-03-16 |
Alpine Roads, Inc. |
Recombinant fusion proteins for producing milk proteins in plants
|
CA3191387A1
(en)
|
2020-09-30 |
2022-04-07 |
Nobell Foods, Inc. |
Recombinant milk proteins and food compositions comprising the same
|
US10894812B1
(en)
|
2020-09-30 |
2021-01-19 |
Alpine Roads, Inc. |
Recombinant milk proteins
|
TW202222841A
(zh)
|
2020-10-06 |
2022-06-16 |
福瑞德哈金森腫瘤研究中心 |
用於治療表現mage-a1之疾病的組成物及方法
|
EP4251746A1
(en)
|
2020-11-30 |
2023-10-04 |
Cellectis SA |
Use of aminoquinoline compounds for higher gene integration
|
CA3201767A1
(en)
|
2020-12-14 |
2022-06-23 |
Thomas M. Schmitt |
Compositions and methods for cellular immunotherapy
|
KR20230156727A
(ko)
|
2021-03-03 |
2023-11-14 |
피에르 파브르 메디카먼트 |
항-vsig4 항체 또는 이의 항원 결합 단편 및 용도
|
AU2022235341A1
(en)
|
2021-03-12 |
2023-09-21 |
Mendus B.V. |
Methods of vaccination and use of cd47 blockade
|
TW202309088A
(zh)
|
2021-04-30 |
2023-03-01 |
法商皮爾法伯製藥公司 |
新的穩定抗vista抗體
|
CA3216563A1
(en)
|
2021-04-30 |
2022-11-03 |
Beatriz Aranda-Orgilles |
New anti-muc1 cars and gene edited immune cells for solid tumors cancer immunotherapy
|
WO2022243531A1
(en)
|
2021-05-20 |
2022-11-24 |
Cellectis S.A. |
Gene therapy for the treatment of severe combined immunodeficiency (scid) related to rag1
|
AU2022276124A1
(en)
|
2021-05-20 |
2023-11-09 |
Albert-Ludwigs-Universität Freiburg |
GENE THERAPY FOR THE TREATMENT OF HYPER-IgE SYNDROME (HIES) BY TARGETED GENE INTEGRATION
|
CA3218475A1
(en)
|
2021-05-21 |
2022-11-24 |
Shipra DAS |
Enhancing efficacy of t-cell-mediated immunotherapy by modulating cancer-associated fibroblasts in solid tumors
|
AU2022299552A1
(en)
|
2021-06-25 |
2024-01-04 |
Oxford Biomedica (Us) Llc |
Adeno-associated virus packaging systems
|
WO2023288281A2
(en)
|
2021-07-15 |
2023-01-19 |
Fred Hutchinson Cancer Center |
Chimeric polypeptides
|
WO2023014922A1
(en)
|
2021-08-04 |
2023-02-09 |
The Regents Of The University Of Colorado, A Body Corporate |
Lat activating chimeric antigen receptor t cells and methods of use thereof
|
EP4392016A1
(en)
|
2021-08-24 |
2024-07-03 |
Oxford Biomedica (US) LLC |
Adeno-associated virus formulations
|
US20230183658A1
(en)
|
2021-10-29 |
2023-06-15 |
Oxford Biomedica Solutions Llc |
Methods and compositions for the purification of adeno-associated virus
|
WO2023081756A1
(en)
|
2021-11-03 |
2023-05-11 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Precise genome editing using retrons
|
GB202117314D0
(en)
|
2021-11-30 |
2022-01-12 |
Clarke David John |
Cyclic nucleic acid fragmentation
|
WO2023102550A2
(en)
|
2021-12-03 |
2023-06-08 |
The Broad Institute, Inc. |
Compositions and methods for efficient in vivo delivery
|
WO2023114901A2
(en)
|
2021-12-15 |
2023-06-22 |
Oxford Biomedica Solutions Llc |
Methods and compositions for the production of adeno-associated virus
|
WO2023141602A2
(en)
|
2022-01-21 |
2023-07-27 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2023215725A1
(en)
|
2022-05-02 |
2023-11-09 |
Fred Hutchinson Cancer Center |
Compositions and methods for cellular immunotherapy
|
WO2023213814A1
(en)
|
2022-05-02 |
2023-11-09 |
Pierre Fabre Medicament |
New formulation of anti vista antibody
|
EP4276174A1
(en)
|
2022-05-09 |
2023-11-15 |
Cellectis S.A. |
Gene therapy for the treatment of activated pi3kinase delta syndrome type 1 (apds1)
|
WO2023233003A1
(en)
|
2022-06-03 |
2023-12-07 |
Cellectis Sa |
Tale base editors for gene and cell therapy
|
WO2024003334A1
(en)
|
2022-06-30 |
2024-01-04 |
Cellectis S.A. |
Enhancing safety of t-cell-mediated immunotherapy
|
WO2024044723A1
(en)
|
2022-08-25 |
2024-02-29 |
Renagade Therapeutics Management Inc. |
Engineered retrons and methods of use
|
WO2024094775A1
(en)
|
2022-11-03 |
2024-05-10 |
Cellectis S.A. |
Enhancing efficacy and safety of t-cell-mediated immunotherapy
|
WO2024121380A1
(en)
|
2022-12-08 |
2024-06-13 |
Pierre Fabre Medicament |
Vaccinal composition and adjuvant
|